Barclays
FURX

Barclays’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Barclays’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-185
Closed -$19K – 8085
2014
Q2 		$19K Sell
185
-136
-42% -$13.3K ﹤0.01% 6552
2014
Q1 		$28K Sell
321
-198
-38% -$15.3K ﹤0.01% 6422
2013
Q4 		$21K Buy
519
+67
+15% +$2.75K ﹤0.01% 6710
2013
Q3 		$20K Sell
452
-3,740
-89% -$155K ﹤0.01% 6542
2013
Q2 		$144K Buy
+4,192
New +$147K ﹤0.01% 5486

Barclays's FURX Position: Q3 2014 in Review

Barclays sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 185 shares — an estimated $19K sold.

Barclays first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $144K in Q2 2013. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Barclays reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Barclays sold 185 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $19K.
  • Barclays first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Barclays's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $144K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.